Analysis of low-benefit subgroups in breast-conserving surgery: Implications for clinical decision-making (Review).

IF 2.3
Experimental and therapeutic medicine Pub Date : 2026-04-08 eCollection Date: 2026-06-01 DOI:10.3892/etm.2026.13150
Weicheng Lin, Lan Luo, Guiping Guo, Huan Lin
{"title":"Analysis of low-benefit subgroups in breast-conserving surgery: Implications for clinical decision-making (Review).","authors":"Weicheng Lin, Lan Luo, Guiping Guo, Huan Lin","doi":"10.3892/etm.2026.13150","DOIUrl":null,"url":null,"abstract":"<p><p>Breast-conserving surgery (BCS) with radiotherapy is a standard treatment for early-stage breast cancer, offering survival outcomes equivalent to mastectomy while preserving breast appearance and improving quality of life. However, BCS suitability and effectiveness vary notably among patients due to differences in age, comorbidities, tumor biology, breast anatomy and psychosocial factors. Through a systematic review, the present study identified six patient subgroups that may derive limited benefit from BCS followed by radiotherapy. These constituted the elderly with multiple comorbidities, those with ductal carcinoma <i>in situ</i>, premenopausal women with aggressive tumor subtypes, patients with cardiac contraindications to radiotherapy, individuals at high risk of poor cosmetic outcomes and those with socioeconomic constraints. For these patients, alternative procedures such as mastectomy with immediate reconstruction may provide improved oncologic or functional results. The present analysis highlights the importance of a personalized, risk-adapted approach to surgical decision-making in breast cancer. By integrating clinical, pathological and sociodemographic variables, the present study supports treatment strategies that are not only valid within oncology but also aligned with the functional needs and psychological well-being of patients.</p>","PeriodicalId":94002,"journal":{"name":"Experimental and therapeutic medicine","volume":"31 6","pages":"155"},"PeriodicalIF":2.3000,"publicationDate":"2026-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13112341/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and therapeutic medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/etm.2026.13150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Breast-conserving surgery (BCS) with radiotherapy is a standard treatment for early-stage breast cancer, offering survival outcomes equivalent to mastectomy while preserving breast appearance and improving quality of life. However, BCS suitability and effectiveness vary notably among patients due to differences in age, comorbidities, tumor biology, breast anatomy and psychosocial factors. Through a systematic review, the present study identified six patient subgroups that may derive limited benefit from BCS followed by radiotherapy. These constituted the elderly with multiple comorbidities, those with ductal carcinoma in situ, premenopausal women with aggressive tumor subtypes, patients with cardiac contraindications to radiotherapy, individuals at high risk of poor cosmetic outcomes and those with socioeconomic constraints. For these patients, alternative procedures such as mastectomy with immediate reconstruction may provide improved oncologic or functional results. The present analysis highlights the importance of a personalized, risk-adapted approach to surgical decision-making in breast cancer. By integrating clinical, pathological and sociodemographic variables, the present study supports treatment strategies that are not only valid within oncology but also aligned with the functional needs and psychological well-being of patients.

保乳手术低获益亚组分析:对临床决策的影响(综述)。
保乳手术(BCS)与放疗是早期乳腺癌的标准治疗方法,在保留乳房外观和提高生活质量的同时,提供与乳房切除术相当的生存结果。然而,由于年龄、合并症、肿瘤生物学、乳房解剖结构和社会心理因素的差异,BCS的适用性和有效性在患者之间存在显著差异。通过系统回顾,本研究确定了六个患者亚组,这些患者可能从BCS和放疗中获得有限的益处。这些患者包括患有多种合并症的老年人、导管原位癌患者、患有侵袭性肿瘤亚型的绝经前妇女、有心脏放射治疗禁忌症的患者、美容效果差的高危人群和社会经济拮据的人群。对于这些患者,其他手术如乳房切除术和立即重建可能提供更好的肿瘤或功能的结果。目前的分析强调了个性化的重要性,风险适应方法的手术决策在乳腺癌。通过整合临床、病理和社会人口学变量,本研究支持的治疗策略不仅在肿瘤学中有效,而且与患者的功能需求和心理健康保持一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书